Immunotherapy

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Javier Melchor, Marcos Garcia-Lacarte, Sara C. Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco J. Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose A. Martinez-Climent, Sergio Roa

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006113; DOI: 10.1136/jitc-2022-006113
Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells
Yue Liu, Joanna Pagacz, Donald J Wolfgeher, Kenneth D Bromerg, Jacob V Gorman, Stephen J Kron

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e005862; DOI: 10.1136/jitc-2022-005862
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody
Xinyu Song, Anwen Xiong, Fengying Wu, Xuefei Li, Jing Wang, Tao Jiang, Peixin Chen, Xiaoshen Zhang, Zhikai Zhao, Huifang Liu, Lei Cheng, Chao Zhao, Zhehai Wang, Chaohu Pan, Xiaoli Cui, Ting Xu, Haitao Luo, Caicun Zhou

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006234; DOI: 10.1136/jitc-2022-006234
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Els M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, Noel F C C de Miranda

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e005887; DOI: 10.1136/jitc-2022-005887
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
Manuel de la Torre-Aláez, Ana Matilla, Maria Varela, Mercedes Iñarrairaegui, Maria Reig, Jose Luis Lledó, Juan Ignacio Arenas, Sara Lorente, Milagros Testillano, Laura Márquez, Leonardo Da Fonseca, Josepmaria Argemí, Carlos Gómez-Martin, Macarena Rodriguez-Fraile, Jose I Bilbao, Bruno Sangro

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005457; DOI: 10.1136/jitc-2022-005457
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Richard J Sové, Babita K Verma, Hanwen Wang, Won Jin Ho, Mark Yarchoan, Aleksander S Popel

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005414; DOI: 10.1136/jitc-2022-005414
Immunostimulatory effects of radioimmunotherapy
Julie Constanzo, Lorenzo Galluzzi, Jean-Pierre Pouget

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e004403; DOI: 10.1136/jitc-2021-004403
Low-dose irradiation for reversing immunotherapy resistance: how to translate?
Maria Ochoa-de-Olza, Jean Bourhis, George Coukos, Fernanda G Herrera

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004939; DOI: 10.1136/jitc-2022-004939
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey Weber, Laura C Cappelli

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006398; DOI: 10.1136/jitc-2022-006398
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
Michael B Atkins, Paolo A Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet Kluger, Ryan J Sullivan, Hussein Tawbi

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005923; DOI: 10.1136/jitc-2022-005923

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages